Active Ingredient: AMPHETAMINE
Proprietary Name: ADZENYS ER
Dosage Form; Route of Administration: SUSPENSION, EXTENDED RELEASE; ORAL
Strength: EQ 1.25MG BASE/ML
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N204325
Product Number: 001
Approval Date: Sep 15, 2017
Applicant Holder Full Name: NEOS THERAPEUTICS INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
